0

Global Estrogen Therapeutics Market 2018-2022

  • Published: Aug 2018
  • Pages: 108
  • SKU: IRTNTR23495
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global estrogen therapeutics market is projected to surpass a value of USD 5.3 billion by 2022. Wondering how to make the most of this thriving industry? Technavio’s comprehensive industry research report presents a holistic overview that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by product type (estrogen gels, oral medication, suppositories, and skin patches), and by region (the Americas, EMEA, and APAC). It also examines the competitive landscape and key market players that include Abbott, Bayer, and Novartis.

The infographic contains a selection of data points and observations from this estrogen therapeutics market report.

The global estrogen therapeutics market is expected to expand at a CAGR of more than 2% during the forecast period

Estrogen therapeutics market growth is expected to accelerate over the next five years, driven by countries around the world. While the Americas will drive the largest growth of almost 50%, EMEA and APAC are also expected to make significant contributions of around 25% each to the incremental growth in the forecast period. The Americas held the largest market share of over 56% in 2017, followed by EMEA with around 26% and APAC accounting for almost 18%. Estrogen plays a vital role in the development of reproductive functions and neurodevelopment in females which has lead to increased R&D of estrogen signaling and alteration in the level of estrogen receptors as a therapeutic target for combating and treating neurodevelopment disorders. Technavio's estrogen therapeutics market analysis reveals promising markets around the world.

 

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

 

Estrogen gels are the leading segment in the market with a revenue share of over 35%

The leading segment in the market is that of estrogen gels, followed by oral medication with a share of almost 32%, suppositories accounting for around 20%, and skin patches with a share of about 19%. Estrogen therapy refers to the estrogen-based treatment of medical conditions using drugs or other methods. Increasing awareness about the benefit of estrogen therapy is likely to drive the demand for the market over the forecast period. However, the market share of skin patches is expected to decline to under 13% by the end of the forecast period. Additionally, the increased benefits of estrogen therapy coupled with growing rates of successful treatment absorption will drive the estrogen therapeutics market growth during the period of forecast.

 

Get more value with Technavio's subscription platform! Gain easy access to all Technavio's reports, along with on-demand services.      Start your 14-day FREE trial

Abbott, Bayer, and Novartis are among leading vendors in the estrogen therapeutics market

As the market continues to flourish, it is growing moderately concentrated with the existence of many well-established large players and regional vendors. The awareness about the negative impact of menopausal symptoms on the quality of life varies widely among different societies and countries. In developed countries, the knowledge regarding occurrence and impact of menopausal symptoms and benefits of estrogen therapy is widespread due to public literacy and health programs initiated by the government. However, a large section of the population in the developing economies possess a lack of knowledge and awareness about estrogen therapy. But the growing awareness about the benefits of estrogen therapy and hormone replacement therapy (HRT) is these emerging economies are forecasted to drive the growth of the market during the period of forecast. Many international and regional vendors are vying for their share of the estrogen therapeutics market, and players must differentiate themselves to gain vital traction over their competitors.

This report offers a complete analysis of several estrogen therapeutics companies, including:

  • Abbott
  • Bayer
  • Novartis
  • Novo Nordisk
  • Pfizer

 

Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements.     Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Estrogen gels – Market size and forecast 2017-2022
  • Oral medication – Market size and forecast 2017-2022
  • Suppositories – Market size and forecast 2017-2022
  • Skin patches – Market size and forecast 2017-2022
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY ESTROGEN TYPE

  • Estradiol
  • Estrone
  • Estetrol
  • Estriol

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Evolution of estrogen as a therapeutic target in neurodevelopmental disorders
  • Development of innovative estrogen delivery systems
  • Increase in FDA approvals for new estrogen therapeutic products

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Bayer
  • Novartis
  • Novo Nordisk
  • Pfizer

PART 16: APPENDIX

  • List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>